340B Advocacy Alliance Bulletin
The AHA, the New Hampshire Hospital Association and 340B Health have filed an amicus brief supporting Mary Hitchcock Memorial Hospital’s request for a preliminary injunction against Eli Lilly’s new 340B claims data policy.
The Department of Health and Human Services’ Health Resources and Services Administration today announced approval of 10 drug companies to participate in the 340B Rebate Model Pilot Program
The Department of Health and Human Services’ Health Resources and Services Administration today announced approval of 10 drug companies to participate in the 340B Rebate Model Pilot Program.
he AHA today submitted comments on the Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act (SECURE 340B Act).
The AHA today told the CMS that a proposal included in the agency’s calendar year 2027 physician fee schedule proposed rule to make reporting mandatory as of Jan. 1, 2027, significantly understates the time, resources and complexity required for hospitals to comply.
The Health Resources and Services Administration’s Office of Pharmacy Affairs Sept. 8 released information on the 340B Office of Pharmacy Affairs Information System Paperwork Reduction Act forms.
The AHA Aug. 26 urged the Centers for Medicare & Medicaid Services not to finalize two proposals in the calendar year 2027 outpatient prospective payment system proposed rule,
The AHA today submitted comments to Sen. Bill Cassidy, R-La., on the 340B Drug Pricing Integrity and Affordability for Patients Act (340B for Patients Act).
Reminder: Submit comments on calendar year 2027 outpatient prospective payment system proposed rule by Aug. 31.
The AHA Aug. 12 at 3 p.m. ET will host a call for 340B hospitals to discuss several aspects of the 340B Drug Pricing Program, including the rebate model and congressional activities.